# POTASSIUM PHOSPHATES
> **ANDA220373** · Abbreviated New Drug Application (Generic) · Sponsor: CAPLIN · Approved 2026-03-12
## Drug
- **FDA Application Number:** ANDA220373
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POTASSIUM PHOSPHATES
- **Generic name:** POTASSIUM PHOSPHATES
- **Active ingredients:** POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** CAPLIN
- **Manufacturer:** Caplin Steriles Limited
- **First approval:** 2026-03-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220373)
---
*MORVS · CC0 1.0*